Status:
COMPLETED
Soy Estrogen Alternative Study (SEA)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Endometrial Hyperplasia
Eligibility:
FEMALE
45-55 years
Phase:
PHASE2
Brief Summary
To conduct a three-armed trial assessing the effect of soy phytoestrogens on menopausal complaints, plasma lipids and lipoproteins, vaginal bleeding and endometrial proliferation, and health related q...
Detailed Description
BACKGROUND: The results of many studies indicate that estrogen replacement therapy (ERT) reduces the risk of coronary heart disease (CHD) in postmenopausal women. However, less than 9 percent of thes...
Eligibility Criteria
Perimenopausal/menopausal women, ages 45 to 55.
Key Trial Info
Start Date :
January 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 1998
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000612
Start Date
January 1 1996
End Date
December 1 1998
Last Update
May 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.